Hepatocellular carcinoma in a patient with focal nodular hyperplasia

HPB

Volumn 4, Issue 3, 2002, Pages 135-138

  Coopersmith, Craig M ^a   Lowell, Jeffrey A ^a   Hassan, Anjum ^a   Howard, Todd K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Focal nodular hyperplasia; Hepatocellular carcinoma; Liver tumour

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DOXORUBICIN; ELECTROLYTE; GEMCITABINE; ORAL CONTRACEPTIVE AGENT;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BENIGN TUMOR; BLOOD CELL COUNT; BLOOD CLOTTING TEST; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRACEPTION; ECHOGRAPHY; FEMALE; FOLLOW UP; FROZEN SECTION; HEMATOCRIT; HEMIHEPATECTOMY; HEPATITIS A; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER FOCAL NODULAR HYPERPLASIA; LIVER NODULE; LIVER TUMOR; LONG TERM CARE; NECROSIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; THROMBOCYTE COUNT; TUMOR BIOPSY;

EID: 0036408869     PISSN: 1365182X     EISSN: None     Source Type: Journal    
DOI: 10.1080/136518202760388046     Document Type: Article

References (35)

1. Brady MS, Coit DG. Focal nodular hyperplasia of the liver. Surg Gynecol Obstet 1990;171:377-81.
2. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991;173:426-31.
3. Kerlin P, Davis GL, McGill DB, Weiland LH et al. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 1983;84:994-1002.
4. Pain JA, Gimson AE, Williams R, Howard ER. Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut 1991;32:524-7.
5. Knowles DM, Casarella WJ, Johnson PM, Wolff M. The clinical, radiologic, and pathologic characterization of benign hepatic neoplasms. Alleged association with oral contraceptives. Medicine 1978;57:223-37.
6. Herman P, Pugliese V, Machado MA, Montagnini AL et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 2000;24:372-6.
7. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975;59:995-1013.
8. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-54.
9. Edmundson HA. Tumors of the liver and intrahepatic bile ducts. In: Atlas of Tumor Pathology. Washington DC: Armed Forces Institute, 1958: Section 7, Fascile 25.
10. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194-200.
11. Kondo F, Nagao T, Sato T, Tomizawa M et al. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract 1998;194:487-95.
12. Kumagai H, Masuda T, Oikawa H, Endo K et al. Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol 2000;15:1344-7.
13. Scott LD, Katz AR, Duke JH, Cowan DF, Maklad NF. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA 1984;251:1461-3.
14. Ross D, Pina J, Mirza M, Galvan A, Ponce L. Letter: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives. Ann Intern Med 1976;85:203-4.
15. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 1977;73:386-94.
16. Cote C. Regression of focal nodular hyperplasia of the liver after oral contraceptive discontinuation. Clin Nucl Med 1997;22:587-90.
17. Mathieu D, Kobeiter H, Maison P, Rahmouni A et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000;118:560-4.
18. Becker YT, Raiford DS, Webb L, Wright JK et al. Rupture and hemorrhage of hepatic focal nodular hyperplasia. Am Surg 1995;61:210-14.
19. Weimann A, Ringe B, Klempnauer J, Lamesch P et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997;21:983-90.
20. Di Stasi M, Caturelli E, De Sio I, Salmi A et al. Natural history of focal nodular hyperplasia of the liver: an ultrasound study. J Clin Ultrasound 1996;24:345-50.
21. Saul SH, Titelbaum DS, Gansler TS, Varello M et al. The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia. Cancer 1987;60:3049-55.
22. Davidson BR, Varsamidakis N, Scheuer P, Hobbs K. Fibrolamellar carcinoma arising in an abnormal liver. J Hepatol 1990;11:388.
23. Saxena R, Humphreys S, Williams R, Portmann B. Nodular hyperplasia surrounding fibrolamellar carcinoma: a zone of arterialized liver parenchyma. Histopathology 1994;25:275-8.
24. Chen TC, Chou TB, Ng KF, Hsieh LL, Chou YH. Hepatocellular carcinoma associated with focal nodular hyperplasia. Report of a case with clonal analysis. Virchows Arch 2001;438:408-11.
25. Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995;19:13-18.
26. Bassel K, Lee M, Seymour NE. Focal nodular hyperplasia of the liver. South Med J 1994;87:918-20.
27. Closset J, Veys I, Peny MO, Braude P et al. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepatogastroenterology 2000;47:1382-4.
28. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR et al. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001;136:1033-8.
29. Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS et al. Management of 155 patients with benign liver tumours. Br J Surg 2001;88:808-13.
30. Hamrick-Turner JE, Shipkey FH, Cranston PE. Fibrolamellar hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia. J Comput Assist Tomogr 1994;18:301-4.
31. Choi CS, Freeny PC. Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of atypical findings. Am J Roentgenol 1998;170:391-5.
32. Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13:397-401.
33. Ruppert-Kohlmayr AJ, Uggowitzer MM, Kugler C, Zebedin D et al. Focal nodular hyperplasia and hepatocellular adenoma of the liver: differentiation with multiphasic helical CT. Am J Roentgenol 2001;176:1493-8.
34. Shiomi S, Kurooka H, Iwata Y, Sasaki N et al. Two cases of focal nodular hyperplasia of the liver: value of scintigraphy with Tc-99m GSA and positron emission tomography with FDG. Ann Nucl Med 1999;13:427-31.
35. Rogers JV, Mack LA, Freeny PC, Johnson ML, Sones PJ. Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy. Am J Roentgenol 1981;137:983-90.